Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, ...
A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...
Bionova Scientific announced Thursday it would bring 200 new jobs to The Woodlands over the next several years, bolstering ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced a moderated digital poster presentation at ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
A top US regulator plans to unveil a faster approach to approving custom gene-editing treatments, a move designed to unleash a wave of industry investment that will yield cures for patients with rare ...
The FDA plans to introduce a faster approval process for custom gene-editing therapies, allowing combined trials for patients with related rare ...
What scientific knowledge is and is not presumed in legal reasoning, and what are the differences between what is and what is ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using programmable “scissors” that make precise edits to DNA to encourage desired ...
With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback